Showing 181 - 200 results of 328 for search '"cognitive decline"', query time: 0.07s Refine Results
  1. 181

    Coexistence of Anti-GAD and Anti-GABAAR Antibodies in an Autoimmune Encephalitis Patient: A Case Report by Lu X, Wu H, Tan Y, Mao X

    Published 2025-01-01
    “…Coexistence of anti-glutamic acid decarboxylase (GAD) and anti-Gamma-aminobutyric acid-α-receptor (GABAAR) antibodies in AE was rare.Case Presentation: A 44-year-old female patient presented to our hospital due to cognitive decline for 4 years, seizures, slowed speech and depression for 2 months. …”
    Get full text
    Article
  2. 182

    Environmental Factors Promoting Neural Plasticity: Insights from Animal and Human Studies by Laura Mandolesi, Francesca Gelfo, Laura Serra, Simone Montuori, Arianna Polverino, Giuseppe Curcio, Giuseppe Sorrentino

    Published 2017-01-01
    “…Some individuals have a cognitive decline earlier and faster than others who are older in years but cerebrally younger. …”
    Get full text
    Article
  3. 183

    The Association between Hypertension and Dementia in the Elderly by Michiya Igase, Katsuhiko Kohara, Tetsuro Miki

    Published 2012-01-01
    “…Recent clinical trials and studies on animal models suggest that blockades of RAS system could have reduced cognitive decline seen in Alzheimer's disease and vascular dementia. …”
    Get full text
    Article
  4. 184

    Investigating the Therapeutic Mechanisms of Total Saikosaponins in Alzheimer’s Disease: A Metabolomic and Proteomic Approach by Huiling Wei, Tianyi Du, Weiwei Zhang, Wei Ma, Yao Yao, Juan Li

    Published 2025-01-01
    “…<b>Conclusions</b>: Our findings suggest that TSS ameliorate cognitive decline through regulating neuroinflammatory pathways, cAMP and cGMP signaling, and synaptic plasticity pathways, providing insights into its therapeutic potential in AD.…”
    Get full text
    Article
  5. 185

    Leveraging transformer models to predict cognitive impairment: accuracy, efficiency, and interpretability by Kai Ma, Junzhi Zhang, Xinhang Huang, Mengyang Wang

    Published 2025-02-01
    “…Conclusion The enhanced Transformer model offers superior accuracy and efficiency in predicting cognitive decline compared to traditional models. Its capacity to process both continuous and categorical data and its interpretability through attention mechanisms make it a promising tool for early detection of neurodegenerative diseases, potentially improving clinical decision-making and interventions.…”
    Get full text
    Article
  6. 186

    Role of insulin-like growth factor-2 in Alzheimer’s disease induced memory impairment and underlying mechanisms by Ruiqi Chen, Xing Lu, Anqi Xiao, Junpeng Ma, Junpeng Ma

    Published 2025-01-01
    “…Insulin-like growth factor-2 (IGF2), which is widely expressed in the central nervous system (CNS), has emerged as a crucial mechanism of synaptic plasticity and learning and memory, and many studies have indicated that this neurotrophic peptide is a viable candidate for treating and preventing AD-induced cognitive decline. An increase in IGF2 levels improves memory in healthy animals and alleviates several symptoms associated with neurodegenerative disorders. …”
    Get full text
    Article
  7. 187

    Relationship between social activities and cognitive impairment in Chinese older adults: the mediating effect of depressive symptoms by Qianke Yang, Shichong Lin, Zhuyun Zhang, Shuhao Du, Dan Zhou

    Published 2025-01-01
    “…BackgroundThe differential impacts of various social activities on dementia prevention and the mediating role of depression in this relationship remain unclear.ObjectivesThis study aimed to identify the effects of different social activities on cognitive function, examine the mediating role of depression, and provide evidence for targeted interventions to prevent cognitive decline.MethodsUsing data from CHARLS, we employed RCS analysis and Structural Equation Modeling to examine the relationships between social activities, depression, and cognitive function in older adults.ResultsSocial activity participation is non-linearly inversely related to both cognitive impairment and depression risk. …”
    Get full text
    Article
  8. 188

    Association of Alzheimer’s and Lewy body disease pathology with basal forebrain volume and cognitive impairment by Julia Schumacher, Stefan Teipel, Alexander Storch

    Published 2025-01-01
    “…We aimed to investigate the relationship between basal forebrain and hippocampus atrophy, cognitive decline, and neuropathology in a large autopsy sample. …”
    Get full text
    Article
  9. 189

    A case report of fatal familial insomnia with cerebrospinal fluid leukocytosis during the COVID-19 epidemic and review of the literature by Zheng Wang, Yueqi Huang, Shuqi Wang, Jiefang Chen, Gesang Meiduo, Man Jin, Xiaoying Zhang

    Published 2024-12-01
    “…Clinical symptoms include psychobehavioral abnormality, cognitive decline, sleep disturbance, and autonomic dysfunction. …”
    Get full text
    Article
  10. 190

    Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy by Ruwei Ou, Wei Song, Qianqian Wei, Ke Chen, Bei Cao, Yanbing Hou, Bi Zhao, Huifang Shang

    Published 2016-01-01
    “…Older PSP patients and late-onset patients are likely to be subjected to cognitive decline.…”
    Get full text
    Article
  11. 191

    Decline in Memory, Visuospatial Ability, and Crystalized Cognitive Abilities in Older Adults: Normative Aging or Terminal Decline? by R. Bendayan, A. M. Piccinin, S. M. Hofer, D. Cadar, B. Johansson, G. Muniz-Terrera

    Published 2017-01-01
    “…Results showed that the time to death model was the best option in analyses of change in all the cognitive measures considered (except for the Information Test). A significant cognitive decline over time was found for all variables. …”
    Get full text
    Article
  12. 192

    A case of mixed dementia with atypical presentation in a veteran by Sujan Poudel, Tejas Patel, Jhoanne Paras, Berdith Lebrun, Gerardo Ferrer, Prerana Upadhyaya, Nisha Panta, Syed Rizvi, Sultan Ahmed

    Published 2024-11-01
    “…This individual exhibit cognitive decline characterized by atypical symptoms, including fugue states, recurrent episodes of flight, and significant amnesia. …”
    Get full text
    Article
  13. 193

    Effects of a 12-Week Exercise Training Program on Physical Function in Institutionalized Frail Elderly by Cristiane Batisti Ferreira, Pâmela dos Santos Teixeira, Geiane Alves dos Santos, Athila Teles Dantas Maya, Paula Americano do Brasil, Vinícius Carolino Souza, Cláudio Córdova, Aparecido Pimentel Ferreira, Ricardo Moreno Lima, Otávio de Toledo Nóbrega

    Published 2018-01-01
    “…However, longevity is usually accompanied by problems such as the loss of functional capacity, cognitive decline, frailty syndrome, and deterioration in anthropometric parameters, particularly among those living in long-term care facilities. …”
    Get full text
    Article
  14. 194

    Exercise and exerkines: Mechanisms and roles in anti-aging and disease prevention by Xuan Lu, Ying Chen, Yue Shi, Yi Shi, Xianbin Su, Peijie Chen, Die Wu, Hui Shi

    Published 2025-02-01
    “…Aging is a complex biological process characterized by increased inflammation and susceptibility to various age-related diseases, including cognitive decline, osteoporosis, and type 2 diabetes. Exercise has been shown to modulate mitochondrial function, immune responses, and inflammatory pathways, thereby attenuating aging through the regulation of exerkines secreted by diverse tissues and organs. …”
    Get full text
    Article
  15. 195

    White Matter Lesion Assessment in Patients with Cognitive Impairment and Healthy Controls: Reliability Comparisons between Visual Rating, a Manual, and an Automatic Volumetrical MR... by Erik Olsson, Niklas Klasson, Josef Berge, Carl Eckerström, Åke Edman, Helge Malmgren, Anders Wallin

    Published 2013-01-01
    “…Age-related white matter lesions (WML) are a risk factor for stroke, cognitive decline, and dementia. Different requirements are imposed on methods for the assessment of WML in clinical settings and for research purposes, but reliability analysis is of major importance. …”
    Get full text
    Article
  16. 196

    Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders by Min Kyu Park, Hyun Wook Yang, Seo Young Woo, Dong Yeon Kim, Dae-Soon Son, Bo Young Choi, Sang Won Suh

    Published 2025-01-01
    “…Elevated PDE4 activity impairs synaptic plasticity by reducing cAMP levels and protein kinase A (PKA) activity, contributing to cognitive decline, acute brain injuries, and neuropsychiatric conditions such as bipolar disorder and schizophrenia. …”
    Get full text
    Article
  17. 197

    Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity by Sung-Soo Jang, Sara E. Royston, Gunhee Lee, Shuwei Wang, Hee Jung Chung

    Published 2016-01-01
    “…Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline. Pathologic accumulation of soluble amyloid-β (Aβ) oligomers impairs synaptic plasticity and causes epileptic seizures, both of which contribute to cognitive dysfunction in AD. …”
    Get full text
    Article
  18. 198

    Superficial Siderosis and Anticoagulation Therapy: Different Presentations, Different Outcomes by Rui Duarte Barreto, Luís Ruano, Vítor Tedim Cruz, Carlos Veira, Paula Coutinho

    Published 2012-01-01
    “…Two Caucasian women, both under long-term oral anticoagulation: a 74 year old woman with slowly progressive hearing loss and mild cerebellar ataxia; a 72 year old woman suffering from behavioural changes, rapidly progressive cognitive decline and latter developing paraparesis. Magnetic resonance imaging showed striking hypointensities along the surfaces of cerebellum, brainstem, frontotemporal cortices, spinal cord, and lumbar arachnoid therefore suggesting superficial siderosis. …”
    Get full text
    Article
  19. 199

    Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β by Mei Wang, Wendi Huang, Juan Huang, Juan Huang, Yong Luo, Yong Luo, Nanqu Huang, Nanqu Huang

    Published 2025-02-01
    “…Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. Glycogen synthase kinase 3β (GSK-3β) plays a pivotal role in AD pathogenesis, particularly in tau protein hyperphosphorylation. …”
    Get full text
    Article
  20. 200

    The Clock Drawing Task reveals executive dysfunction in the dialysis population – an underrecognized and underestimated problem by Piotr Olejnik, Aleksandra Golenia, Oliwia Maciejewska, Ewa Wojtaszek, Paweł Żebrowski, Jolanta Małyszko

    Published 2024-12-01
    “…Yet, it remains underdiagnosed, even though it may significantly influence the lives of patients.Materials and methods In this cross-sectional, prospective study, 58 dialysis patients with no cognitive decline on the MMSE screening were assessed for executive function impairment using the Executive Clock-Drawing Task (CLOX). …”
    Get full text
    Article